Article by Alise Kalane Adolescence is nestled between two transitions — the end of childhood and the beginning of adulthood — with malleable borders.
CategoryMind & Health
Will I Live Longer If I Learn?
The Preston curve, true or false? Article by Anna Mind In 1975 Samuel Preston drew the first “Preston curve”, which showed that the more money or income (horizontal axis) person had, the longer he/she lived (vertical axis) – clearly showing a high correlation and therefore statistically significant.
The Most Severe Parasitic Infections After Malaria
Article by Rajlakshmi Sohini Mukhopadhyay Seventeen brave volunteers in Leiden were asked to let their bodies be used in the research of a deadly parasitic disease.
Man-flu: Myth or Fact?
Article by Rajlakshmi Sohini Mukhopadhyay What is Man-flu? It’s winter and the time of year for the flu and colds to hit our immune systems with a vengeance.
A Caffeinated Heart, a Healthy Heart?
Our worlds are busy and, more often than not, we turn to caffeine as a way of keeping us going through our hectic day. The buzz of a morning coffee, or lack of it, can often feel like it can make or break a day.
Foreign language can change our belief in superstitions.
It’s often believed that speaking a foreign language can change your personality. Operating in a foreign language could have some interesting psychological effects…
What Your Sense of Smell Can Say About Your Neurological Health
The loss of the sense of smell was a better predictor of death than a diagnosis of heart failure, cancer or lung disease.
The Body – Its Own Enemy?
Sitting at the bedside of a patient at the nephrology department of a London hospital, I realise the importance of even the rarest of conditions and how it can truly affect a person’s life.
Genome editing tool – CRISPR eliminates HIV infection in mice.
Researchers have developed and demonstrated the successful removal of HIV-1 provirus from mice organs and tissue completely. By using a gene-editing technique called CRISPR
HIV Vaccine phase II clinical trials have begun
SAV001, an HIV vaccine developed by Chil-Yong Kang and a research team at Western’s Schulich School of Medicine has successfully completed phase 1 trials. The results of the Phase I trial were